| | | | | Präparat | Packungsgrösse | EFP | PP | SB | TK | Zusammensetzung | Zulassungsinhaber | Kat. | | | | |
---|
|
| | FI | PI | | Gavisconell Liquid Mint | 300 ml | 5.83 | 10.75 | 10% | | Suspension zum Einnehmen in Flaschen: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D / SL | FB | | G |  |
| | FI | PI | | Gaviscon Mint | 8 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Erdbeer | 8 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Mint | 16 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Erdbeer | 16 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Erdbeer | 24 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Mint | 32 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Erdbeer | 32 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Mint | 48 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Erdbeer | 48 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Mint | 64 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Erdbeer | 64 Tablette(n) | PA | PA | k.A. | | Kautabletten: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gavisconell Liquid Mint | 150 ml | PA | PA | k.A. | | Suspension zum Einnehmen in Flaschen: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Liquid Mint | 12 Sachet(s) | PA | PA | k.A. | | Suspension zum Einnehmen in Sachets: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Gaviscon Liquid Mint | 24 Sachet(s) | PA | PA | k.A. | | Suspension zum Einnehmen in Sachets: 3 Wirkstoffe | Reckitt Benckiser (Switzerland) AG | D | FB | | G |  |
| | FI | PI | | Refluxin | 30 Tablette(n) | PA | 9.10 | k.A. | | Tabletten: 3 Wirkstoffe | Spirig Pharma AG | D / SO | FB | | G |  |
| | FI | PI | | Refluxin | 150 Tablette(n) | PA | 35.55 | k.A. | | Tabletten: 3 Wirkstoffe | Spirig Pharma AG | D / SO | FB | | G |  |
| | FI | PI | | Alumagall | 27 Tablette(n) | PA | 8.95 | k.A. | | Lutschtabletten: 3 Wirkstoffe | Perrigo Schweiz AG | D | FB | | G |  |
| | | | | Magentee H | 110 g | PA | PA | k.A. | | Geschnittene Kräuter: 13 Wirkstoffe | Hänseler AG | D | FB | | G |  |
| | | | | Gastrikur | 200 g | PA | 8.50 | k.A. | | Pulver: 3 Wirkstoffe | Pharma-Med AG | D | FB | | G |  |
| | FI | PI | | Magenpulver Hafter AA | 50 g | PA | PA | k.A. | | Pulver: 3 Wirkstoffe | G. Streuli & Co. AG | B | FB | | G |  |
| | FI | PI | | Magenpulver Hafter AA | 100 g | PA | 13.90 | k.A. | | Pulver: 3 Wirkstoffe | G. Streuli & Co. AG | B | FB | | G |  |
| | FI | PI | | Magentabletten Hafter 15 Streuli | 30 Tablette(n) | PA | 7.30 | k.A. | | Tabletten: 2 Wirkstoffe | G. Streuli & Co. AG | B | FB | | G |  |
| | | PI | | Gaviscon | 200 ml | PA | 12.90 | k.A. | | Suspension (oral): 4 Wirkstoffe | NOVARTIS CONSUMER HEALTH SCHWEIZ AG | D | FB | | G |  |